Clinical trial
Study on Efficacy and Safety of Huangqi Guizhi Wuwu Decoction Treatment for Oxaliplatin Induced Peripheral Neurotoxicity: a Protocol for a Randomized, Controlled, Double-blind, Multi-center Trial
NCT04261920 is registered in ClinicalTrials.gov with Jiangsu Famous Medical Technology Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on Efficacy and Safety of Huangqi Guizhi Wuwu Decoction Treatment for Oxaliplatin Induced Peripheral Neurotoxicity: a Protocol for a Randomized, Controlled, Double-blind, Multi-center Trial
- Lead sponsor
- Jiangsu Famous Medical Technology Co., Ltd.
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- January 3, 2020
- Completion date
- March 2, 2023
- Enrollment
- 360 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
oncology